BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32971499)

  • 1. The current status and challenges in multiple sclerosis management in the Philippines.
    Ignacio KHD; Espiritu AI; Jamora RDG
    Mult Scler Relat Disord; 2020 Nov; 46():102510. PubMed ID: 32971499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune Encephalitis in the Philippines: A Scoping Review on the Treatment Gaps, Challenges, and Current State of Care.
    Pagaling GT; Turalde CWR; Jamora RDG
    Front Neurol; 2022; 13():788309. PubMed ID: 35197921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status and challenges in the care of patients with bacterial meningitis in the Philippines: A scoping review.
    Ocampo FF; Espiritu AI; Jamora RDG
    Trop Med Int Health; 2022 Jan; 27(1):38-48. PubMed ID: 34861085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment gaps and challenges in epilepsy care in the Philippines.
    Moalong KMC; Espiritu AI; Fernandez MLL; Jamora RDG
    Epilepsy Behav; 2021 Feb; 115():107491. PubMed ID: 33323340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment gaps in the care of amyotrophic lateral sclerosis in the Philippines: A scoping review.
    Ditan ID; Turalde CWR
    Heliyon; 2024 Mar; 10(6):e27944. PubMed ID: 38510000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment gaps in Parkinson's disease care in the Philippines.
    Jamora RDG; Miyasaki JM
    Neurodegener Dis Manag; 2017 Aug; 7(4):245-251. PubMed ID: 28853633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Status and Challenges in Dementia Care in the Philippines: A Scoping Review.
    Anlacan VMM; Lanuza PDT; Sanchez AAR; Jamora RDG
    J Alzheimers Dis; 2024; 97(4):1533-1543. PubMed ID: 38306035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Out-of-pocket medical expenses for inpatient care among beneficiaries of the National Health Insurance Program in the Philippines.
    Tobe M; Stickley A; del Rosario RB; Shibuya K
    Health Policy Plan; 2013 Aug; 28(5):536-48. PubMed ID: 23048125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The catastrophic out-of-pocket health expenditure of multiple sclerosis patients in Iran.
    Gharibi F; Imani A; Dalal K
    BMC Health Serv Res; 2021 Mar; 21(1):257. PubMed ID: 33743679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of hypertension care and management in the Philippines.
    Dela Rosa JGL; Catral CDM; Reyes NA; Opiso DMS; Ong EP; Ornos EDB; Santos JR; Quebral EPB; Callanta MLJ; Oliva RV; Tantengco OAG
    Diabetes Metab Syndr; 2024 Apr; 18(4):103008. PubMed ID: 38640838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost analysis of multiple sclerosis in Brazil: a cross-sectional multicenter study.
    da Silva NL; Takemoto MLS; Damasceno A; Fragoso YD; Finkelsztejn A; Becker J; Gonçalves MVM; Tilbery C; de Oliveira EML; Callegaro D; Boulos FC
    BMC Health Serv Res; 2016 Mar; 16():102. PubMed ID: 27009599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sclerosis: relapses, resource use, and costs.
    Hawton AJ; Green C
    Eur J Health Econ; 2016 Sep; 17(7):875-84. PubMed ID: 26438399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation Oncology in the Philippines: Current State and Future Directions.
    Vergara TVT; Chua TMC; Santi KMG; Magsanoc JMJ; Peña-Camacho A; Vega GP; Calaguas MJC
    Adv Radiat Oncol; 2024 Feb; 9(2):101354. PubMed ID: 38405322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI utilization during the diagnostic and post-diagnostic phases in multiple sclerosis.
    Wijnands JMA; Ekuma O; Kingwell E; Zhu F; Zhao Y; Fisk JD; Evans C; Tremlett H; Marrie RA
    Mult Scler Relat Disord; 2019 Feb; 28():138-144. PubMed ID: 30594814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approaches and challenges in the diagnosis and management of secondary progressive multiple sclerosis: A Central Eastern European perspective from healthcare professionals.
    Boyko A; Therapontos C; Horakova D; Szilasiová J; Kalniņa J; Kolontareva J; Gross-Paju K; Selmaj K; Sereike I; Milo R; Gabelić T; Rot U
    Mult Scler Relat Disord; 2021 May; 50():102778. PubMed ID: 33592384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost Sharing of Disease-Modifying Treatments (DMTs) as Policy Lever to Improve DMTs' Access in Multiple Sclerosis.
    Shao H; Stoecker C; Monnette AM; Shi L
    Value Health; 2018 Sep; 21(9):1083-1089. PubMed ID: 30224113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of diabetes mellitus care and management in the Philippines.
    Cando LFT; Quebral EPB; Ong EP; Catral CDM; Relador RJL; Velasco AJD; Alcazar RMU; Reyes NAL; Pilotin EJB; Ornos EDB; Paz-Pacheco E; Tantengco OAG
    Diabetes Metab Syndr; 2024 Feb; 18(2):102951. PubMed ID: 38382166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evaluation of operating Animal Bite Treatment Centers in the Philippines from a health provider perspective.
    Amparo ACB; Jayme SI; Roces MCR; Quizon MCL; Villalon EES; Quiambao BP; Baquilod MS; Hernandez LM; Taylor LH; Nel LH
    PLoS One; 2018; 13(7):e0199186. PubMed ID: 30001378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health care services and disease modifying therapies use in community-based multiple sclerosis patients: Evolution from 2013 to 2015 and demographic characteristics.
    Ha-Vinh P; Nauleau S; Clementz M; Régnard P; Sauze L; Clavaud H
    Presse Med; 2019 Jan; 48(1 Pt 1):e1-e19. PubMed ID: 30528148
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.